Literature DB >> 8745066

Anorectic and neurochemical effects of pituitary adenylate cyclase activating polypeptide in rats.

W T Chance1, H Thompson, I Thomas, J E Fischer.   

Abstract

Pretreatment of rats with intrahypothalamic injections of pituitary adenylate cyclase activating peptide (PACAP) 10 min prior to the injection of neuropeptide Y (NPY) significantly reduced food and water intake during the 4-h measurement period. Intrahypothalamic injection of PACAP in schedule-fed rats also reduced food and water intake for 2 h. A smaller 1-h reduction of water intake was observed in water-deprived rats, suggesting that the anticonsummatory effects of PACAP were primarily against food intake. PACAP treatment did not alter hypothalamic concentration of NPY, nor were neurotransmitters, precursors, or metabolites altered substantially in corpus striatum or nucleus accumbens regions. These results demonstrate primary anorectic effects of intrahypothalamic injection of PACAP. The demonstration of these anorectic effects may suggest a role of cyclic AMP activation and inhibition in the control of satiety and hunger.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8745066     DOI: 10.1016/0196-9781(95)02048-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  19 in total

1.  Stimulation of the hypothalamic ventromedial nuclei by pituitary adenylate cyclase-activating polypeptide induces hypophagia and thermogenesis.

Authors:  Jon M Resch; Joanne P Boisvert; Allison E Hourigan; Christopher R Mueller; Sun Shin Yi; Sujean Choi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

2.  Pituitary Adenylate Cyclase-Activating Peptide in the Central Amygdala Causes Anorexia and Body Weight Loss via the Melanocortin and the TrkB Systems.

Authors:  Attilio Iemolo; Antonio Ferragud; Pietro Cottone; Valentina Sabino
Journal:  Neuropsychopharmacology       Date:  2015-02-04       Impact factor: 7.853

3.  CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP.

Authors:  Riccardo Dore; Attilio Iemolo; Karen L Smith; Xiaofan Wang; Pietro Cottone; Valentina Sabino
Journal:  Neuropsychopharmacology       Date:  2013-05-09       Impact factor: 7.853

Review 4.  Melanocortin neurons: Multiple routes to regulation of metabolism.

Authors:  Wen-Jie Shen; Ting Yao; Xingxing Kong; Kevin W Williams; Tiemin Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-09       Impact factor: 5.187

Review 5.  Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.

Authors:  Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2014-12-09       Impact factor: 13.382

6.  Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN).

Authors:  Seth D Norrholm; Mahasweta Das; Gábor Légrádi
Journal:  Regul Pept       Date:  2005-05-15

7.  Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene.

Authors:  Anika Agarwal; Lisa M Halvorson; Gabor Legradi
Journal:  Brain Res Mol Brain Res       Date:  2005-07-29

8.  PACAP in the BNST produces anorexia and weight loss in male and female rats.

Authors:  Margaret Kocho-Schellenberg; Kimberly R Lezak; Olivia M Harris; Erin Roelke; Niklas Gick; Inyop Choi; Shaquille Edwards; Emily Wasserman; Donna J Toufexis; Karen M Braas; Victor May; Sayamwong E Hammack
Journal:  Neuropsychopharmacology       Date:  2014-01-17       Impact factor: 7.853

9.  Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide.

Authors:  Bruce A Adams; Sarah L Gray; Emma R Isaac; Antonio C Bianco; Antonio J Vidal-Puig; Nancy M Sherwood
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

10.  PAC1 receptor antagonism in the bed nucleus of the stria terminalis (BNST) attenuates the endocrine and behavioral consequences of chronic stress.

Authors:  Carolyn W Roman; Kim R Lezak; Matthew J Hartsock; William A Falls; Karen M Braas; Alan B Howard; Sayamwong E Hammack; Victor May
Journal:  Psychoneuroendocrinology       Date:  2014-05-27       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.